Close

More on CME

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+1.2% Growth)
- Ratings (3.5 Score)
- Holders
- Dividends (2.1% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/24/24)
- Annual Meeting (5/9/2024)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CME Cash Flow Statement

Click line-items for a historical chart and %
Cash Flows from Operating Activities
Net income 1.16B
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation 42.3M
Amortization of purchased intangibles 72M
Depreciation and amortization 95.5M
Credit Market Analysis Limited impairment
Net accretion of discounts and amortization of debt financing costs
Gain on sale of Index Services assets
Equity in net losses of unconsolidated subsidiaries
Deferred income taxes -79.3M
Change in assets and liabilities:
Accounts receivable -18.7M
Other current assets -12.5M
Other assets 9.5M
Accounts payable 5.7M
Income tax payable 21.3M
Other current liabilities -67.3M
Other liabilities -14.3M
Other -700K
Net Cash Provided by Operating Activities 1.21B
Cash Flows from Investing Activities
Proceeds from maturities of available-for-sale marketable securities 40.1M
Purchases of available-for-sale marketable securities -44.9M
Purchases of property, net -62.9M
Cash acquired from Index Services
Proceeds from sale of Index Services assets
Proceeds from Chicago Board Options Exchange exercise right privileges
Other
Net Cash Used in Investing Activities -63.8M
Cash Flows from Financing Activities
Proceeds (repayments) of commercial paper, net
Proceeds from other borrowings, net of issuance costs
Repayment of other borrowings
Cash dividends -1.58B
Repurchase of Class A common stock, including costs
Proceeds from exercise of stock options 29.5M
Distribution paid to non-controlling interest
Excess tax benefits related to employee option exercises and restricted stock vesting 10M
Other 900K
Net Cash Used in Financing Activities -1.41B
Net change in cash and cash equivalents -272.1M
Cash and cash equivalents, beginning of period 1.69B
Cash and Cash Equivalents, End of Period 1.42B
Supplemental Disclosure of Cash Flow Information
Income taxes paid 545.5M
Interest paid 84.8M
Non-cash investing activities:
Change in net unrealized securities gains (losses)
Change in net unrealized derivatives gains (losses)